[Body mass loss due to orlistat therapy and multiple factors of cardiovascular risk].

Mychka, V B

[Body mass loss due to orlistat therapy and multiple factors of cardiovascular risk]. [electronic resource] - Terapevticheskii arkhiv 2005 - 55-60 p. digital

Publication Type: Clinical Trial; Journal Article

0040-3660


Adult
Anti-Obesity Agents--adverse effects
Blood Glucose--metabolism
Cardiovascular Diseases--etiology
Cerebral Angiography
Female
Humans
Insulin--blood
Insulin Resistance
Lactones--adverse effects
Lipid Metabolism
Lipids--blood
Male
Metabolic Syndrome--complications
Orlistat
Risk Factors
Weight Loss